4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000002
Options or other derivatives
- Chief Strategy Officer acquired 95,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Riley Jennifer Chief Strategy Officer | 2026-02-26 | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | D | ||
Loading xslF345X05/form4-03022026_090329.xml…